Hyperglycemia Novo Nordisk

News

Novo Nordisk, Hims & hers health and Wegovy

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%

Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.

Seeking Alpha on MSN · 18h

Hims & Hers surges on partnership with Novo Nordisk for Wegovy

Hims & Hers Health (HIMS) stock surges following a partnership with Novo Nordisk (NVO) to sell the Danish drugmaker's weight loss drug, Wegovy. Read more here.

Yahoo Finance on MSN · 17h

Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership

Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with it and other telehealth platforms to offer patients access to the blockbuster weight loss drug Wegovy.

Medscape2mon

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

GI, gastrointestinal. Disclosure: D.M.N. has received research grants for investigator-initiated research from Aventis and Novo Nordisk. Disclosure: J.B.B. has conducted research and/or served on ...

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk, Hims & hers health and Wegovy

Trending now